loading
Precedente Chiudi:
$31.35
Aprire:
$31.41
Volume 24 ore:
356.06K
Relative Volume:
0.61
Capitalizzazione di mercato:
$1.69B
Reddito:
$651.97M
Utile/perdita netta:
$59.71M
Rapporto P/E:
30.12
EPS:
1.0696
Flusso di cassa netto:
$172.03M
1 W Prestazione:
+4.75%
1M Prestazione:
-2.51%
6M Prestazione:
-5.04%
1 anno Prestazione:
+9.93%
Intervallo 1D:
Value
$31.16
$32.36
Intervallo di 1 settimana:
Value
$29.87
$32.36
Portata 52W:
Value
$25.53
$40.28

Supernus Pharmaceuticals Inc Stock (SUPN) Company Profile

Name
Nome
Supernus Pharmaceuticals Inc
Name
Telefono
301-838-2500
Name
Indirizzo
9715 KEY WEST AVENUE, ROCKVILLE, MD
Name
Dipendente
674
Name
Cinguettio
@Supernus_Pharma
Name
Prossima data di guadagno
2024-11-04
Name
Ultimi documenti SEC
Name
SUPN's Discussions on Twitter

Confronta SUPN con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Drug Manufacturers - Specialty & Generic icon
SUPN
Supernus Pharmaceuticals Inc
32.22 1.69B 651.97M 59.71M 172.03M 1.0696
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
153.47 65.50B 9.26B 2.49B 2.30B 5.47
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
15.03 46.99B 30.25B 1.37B 5.08B 0.4257
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
10.18 45.96B 14.35B 1.85B 0 0.4023
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
14.87 17.04B 16.54B -1.64B 749.00M -1.45
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
291.38 12.77B 2.76B 1.11B 898.10M 22.77

Supernus Pharmaceuticals Inc Stock (SUPN) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-02-19 Downgrade Cantor Fitzgerald Overweight → Neutral
2025-01-06 Iniziato Cantor Fitzgerald Overweight
2024-09-11 Downgrade Piper Sandler Overweight → Neutral
2023-01-03 Ripresa Jefferies Buy
2021-12-01 Ripresa Jefferies Buy
2021-04-13 Aggiornamento Jefferies Hold → Buy
2020-06-16 Aggiornamento Piper Sandler Neutral → Overweight
2020-06-15 Ripresa Jefferies Hold
2019-11-08 Downgrade Berenberg Buy → Hold
2019-11-07 Downgrade Stifel Buy → Hold
2019-11-06 Downgrade Jefferies Buy → Hold
2018-11-12 Reiterato B. Riley FBR Buy
2018-01-18 Reiterato B. Riley FBR, Inc. Buy
2017-12-28 Reiterato B. Riley FBR, Inc. Buy
2017-12-04 Aggiornamento Janney Neutral → Buy
2017-11-08 Aggiornamento Stifel Hold → Buy
2017-10-19 Iniziato FBR & Co. Buy
2017-09-19 Downgrade Stifel Buy → Hold
2017-07-17 Downgrade Piper Jaffray Overweight → Neutral
2017-07-14 Iniziato Janney Neutral
2017-06-01 Aggiornamento Piper Jaffray Neutral → Overweight
2016-07-18 Downgrade Northland Capital Outperform → Market Perform
2016-07-18 Downgrade Piper Jaffray Overweight → Neutral
2016-02-08 Aggiornamento Jefferies Hold → Buy
2015-11-05 Reiterato Northland Capital Outperform
2015-10-28 Iniziato Northland Capital Outperform
Mostra tutto

Supernus Pharmaceuticals Inc Borsa (SUPN) Ultime notizie

pulisher
04:38 AM

LPL Financial LLC Increases Holdings in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) - Defense World

04:38 AM
pulisher
04:03 AM

Wells Fargo & Company MN Boosts Stock Holdings in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) - Defense World

04:03 AM
pulisher
Apr 25, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 25, 2025
pulisher
Apr 25, 2025

Bank of Montreal Can Buys 473 Shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) - Defense World

Apr 25, 2025
pulisher
Apr 24, 2025

3 Healthcare Stocks with Mounting Challenges - Yahoo Finance

Apr 24, 2025
pulisher
Apr 23, 2025

Supernus Pharmaceuticals to Announce First Quarter 2025 Financial Results and Host Conference Call and Webcast on May 6, 2025 | SUPN Stock News - GuruFocus

Apr 23, 2025
pulisher
Apr 23, 2025

Supernus Pharmaceuticals to Announce First Quarter 2025 Financial Results and Host Conference Call and Webcast on May 6, 2025 - The Manila Times

Apr 23, 2025
pulisher
Apr 23, 2025

Supernus Pharmaceuticals, Inc. to Announce First Quarter 2025 Financial Results on May 6, 2025 - Nasdaq

Apr 23, 2025
pulisher
Apr 23, 2025

Supernus Pharmaceuticals to Announce First Quarter 2025 - GlobeNewswire

Apr 23, 2025
pulisher
Apr 23, 2025

Supernus Q1 2025 Earnings Preview: CEO Jack Khattar to Detail Financial Performance May 6 - Stock Titan

Apr 23, 2025
pulisher
Apr 20, 2025

Federated Hermes Inc. Has $58,000 Stock Position in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) - Defense World

Apr 20, 2025
pulisher
Apr 19, 2025

(SUPN) Long Term Investment Analysis - news.stocktradersdaily.com

Apr 19, 2025
pulisher
Apr 17, 2025

Is Supernus Pharmaceuticals, Inc. (SUPN) the Best Pharma Stock to Buy for Long Term Growth? - Insider Monkey

Apr 17, 2025
pulisher
Apr 17, 2025

Supernus Pharmaceuticals (NASDAQ:SUPN) Stock Rating Upgraded by StockNews.com - Defense World

Apr 17, 2025
pulisher
Apr 16, 2025

Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Stock Holdings Lifted by Franklin Resources Inc. - Defense World

Apr 16, 2025
pulisher
Apr 15, 2025

JPMorgan Chase & Co. Acquires 44,414 Shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) - Defense World

Apr 15, 2025
pulisher
Apr 14, 2025

10 Best Pharma Stocks to Buy for Long Term Growth - Insider Monkey

Apr 14, 2025
pulisher
Apr 14, 2025

Levi & Korsinsky Reminds Shareholders of an Investigation into Supernus Pharmaceuticals, Inc. (SUPN) Regarding Potential Securities Fraud Allegations - ACCESS Newswire

Apr 14, 2025
pulisher
Apr 14, 2025

Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Shares Acquired by Geode Capital Management LLC - Defense World

Apr 14, 2025
pulisher
Apr 14, 2025

Wellington Management Group LLP Sells 2,826 Shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) - Defense World

Apr 14, 2025
pulisher
Apr 13, 2025

SUPN stock soars to 52-week high, hits $39.38 amid growth - MSN

Apr 13, 2025
pulisher
Apr 12, 2025

Shareholders that lost money on Supernus Pharmaceuticals, Inc.(SUPN) should contact Levi & Korsinsky about Securities Fraud InvestigationSUPN - ACCESS Newswire

Apr 12, 2025
pulisher
Apr 11, 2025

Supernus Pharmaceuticals (NASDAQ:SUPN) Stock Rating Lowered by StockNews.com - Defense World

Apr 11, 2025
pulisher
Apr 10, 2025

Levi & Korsinsky Investigates Possible Securities Fraud Violations by Supernus Pharmaceuticals, Inc. (SUPN) - ACCESS Newswire

Apr 10, 2025
pulisher
Apr 10, 2025

Norges Bank Makes New Investment in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) - Defense World

Apr 10, 2025
pulisher
Apr 09, 2025

Rep. Gilbert Ray Cisneros, Jr. Purchases Shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) - Defense World

Apr 09, 2025
pulisher
Apr 08, 2025

Supernus Pharmaceuticals, Inc. Investigated Regarding Potential Securities Law ViolationsContact Levi & Korsinsky for DetailsSUPN - ACCESS Newswire

Apr 08, 2025
pulisher
Apr 08, 2025

Arrowstreet Capital Limited Partnership Purchases 77,393 Shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) - The AM Reporter

Apr 08, 2025
pulisher
Apr 08, 2025

Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Shares Sold by Commonwealth Equity Services LLC - Defense World

Apr 08, 2025
pulisher
Apr 07, 2025

ATTENTION Supernus Pharmaceuticals, Inc. Investors: You May Have Been Affected by FraudContact Levi & Korsinsky to Discuss Your Rights - ACCESS Newswire

Apr 07, 2025
pulisher
Apr 06, 2025

Vanguard Group Inc. Has $222.41 Million Position in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) - Defense World

Apr 06, 2025
pulisher
Apr 04, 2025

Lost Money on Supernus Pharmaceuticals, Inc. (SUPN)? You May Have Been Affected by FraudContact Levi & Korsinsky - ACCESS Newswire

Apr 04, 2025
pulisher
Apr 04, 2025

Supernus Pharmaceuticals (SUPN): Buy, Sell, or Hold Post Q4 Earnings? - Yahoo Finance

Apr 04, 2025
pulisher
Apr 02, 2025

Several Supernus Pharmaceuticals Insiders Sell Shares Sending Potential Negative Signal - simplywall.st

Apr 02, 2025
pulisher
Apr 02, 2025

Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Shares Bought by HighTower Advisors LLC - Defense World

Apr 02, 2025
pulisher
Apr 02, 2025

Supernus Pharmaceuticals (NASDAQ:SUPN) Upgraded by StockNews.com to “Strong-Buy” Rating - Defense World

Apr 02, 2025
pulisher
Mar 31, 2025

An Investigation Has Commenced on Behalf of Supernus Pharmaceuticals, Inc. Shareholders. Contact Levi & Korsinsky to Discuss your SUPN Losses. - ACCESS Newswire

Mar 31, 2025
pulisher
Mar 31, 2025

Thrivent Financial for Lutherans Sells 591 Shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) - Defense World

Mar 31, 2025
pulisher
Mar 31, 2025

Teacher Retirement System of Texas Has $591,000 Holdings in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) - Defense World

Mar 31, 2025
pulisher
Mar 27, 2025

ATTENTION SUPN SHAREHOLDERS: Investors who lost money on Supernus Pharmaceuticals, Inc. are urged to contact Levi & Korsinsky about an ongoing investigation - ACCESS Newswire

Mar 27, 2025
pulisher
Mar 26, 2025

Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Shares Acquired by Swiss National Bank - Defense World

Mar 26, 2025
pulisher
Mar 25, 2025

Supernus Pharmaceuticals (NASDAQ:SUPN) Downgraded to “Buy” Rating by StockNews.com - Defense World

Mar 25, 2025
pulisher
Mar 25, 2025

11,282 Shares in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Acquired by Proficio Capital Partners LLC - Defense World

Mar 25, 2025
pulisher
Mar 25, 2025

Supernus Pharmaceuticals, Inc. INVESTIGATION: Levi & Korsinsky Investigates Potential Securities Fraud by Supernus Pharmaceuticals, Inc. (SUPN) - ACCESS Newswire

Mar 25, 2025
pulisher
Mar 24, 2025

Raymond James Financial Inc. Takes $6.85 Million Position in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) - Defense World

Mar 24, 2025
pulisher
Mar 24, 2025

Taking a Closer Look At Supernus Pharmaceuticals Inc (SUPN) Following Its Recent Trade - knoxdaily.com

Mar 24, 2025
pulisher
Mar 23, 2025

(SUPN) Trading Report - news.stocktradersdaily.com

Mar 23, 2025
pulisher
Mar 21, 2025

SUPN ACTIVE INVESTIGATION: Contact Levi & Korsinsky if You Lost Money on Your Supernus Pharmaceuticals, Inc. Investment - ACCESS Newswire

Mar 21, 2025
pulisher
Mar 20, 2025

PNC Financial Services Group Inc. Sells 362 Shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) - Defense World

Mar 20, 2025
pulisher
Mar 18, 2025

Atria Investments Inc Invests $288,000 in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) - Defense World

Mar 18, 2025
pulisher
Mar 18, 2025

Charles Schwab Investment Management Inc. Purchases 40,968 Shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) - Defense World

Mar 18, 2025

Supernus Pharmaceuticals Inc Azioni (SUPN) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Supernus Pharmaceuticals Inc Azioni (SUPN) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
DEC TIMOTHY C
Senior Vice-President & CFO
Mar 10 '25
Option Exercise
0.00
3,800
0
13,636
Khattar Jack A.
President, CEO
Mar 07 '25
Option Exercise
0.00
38,640
0
992,219
Mottola Frank
SVP, Quality, GMP, Ops, IT
Mar 07 '25
Option Exercise
0.00
2,625
0
16,507
Mottola Frank
SVP, Quality, GMP, Ops, IT
Feb 26 '25
Option Exercise
0.00
5,760
0
17,683
Bhatt Padmanabh P.
Sr. VP of IP, CSO
Feb 21 '25
Option Exercise
0.00
1,650
0
11,799
Rubin Jonathan
SVP, Chief Medical Officer
Feb 21 '25
Option Exercise
0.00
1,875
0
8,780
Rubin Jonathan
SVP, Chief Medical Officer
Feb 21 '25
Sale
39.15
927
36,292
7,853
Mottola Frank
SVP, Quality, GMP, Ops, IT
Feb 21 '25
Option Exercise
0.00
1,125
0
9,576
Bhatt Padmanabh P.
Sr. VP of IP, CSO
Feb 04 '25
Option Exercise
29.61
9,477
280,614
19,626
Bhatt Padmanabh P.
Sr. VP of IP, CSO
Feb 04 '25
Sale
39.70
9,477
376,237
10,149
$9.46
price up icon 0.00%
$27.84
price up icon 0.61%
$101.77
price down icon 1.80%
$8.13
price up icon 1.25%
$106.73
price up icon 0.92%
$291.38
price down icon 1.70%
Capitalizzazione:     |  Volume (24 ore):